We have previously reported that TβRI undergoes proteolytic cleavage in cancer cells, whereby TβRI-ICD is released from the membrane and is translocated into the nucleus, however, the molecular mechanism involved is not known [12, 13]. Here, TGFBR1 is linked to cancer.